Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 143, Issue 5 SUPPL, 2013, Pages

  Deng, Gary E ^a   Rausch, Sarah M ^b   Jones, Lee W ^d   Gulati, Amitabh ^a   Kumar, Nagi B ^c   Greenlee, Heather ^e   Pietanza, M Catherine ^a   Cassileth, Barrie R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d DUKE CANCER INSTITUTE   (United States)

^e Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CAROTENE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; RETINOL;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANXIETY DISORDER; ARTICLE; CACHEXIA; CALORIC INTAKE; CANCER PAIN; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; DIET THERAPY; EVIDENCE BASED PRACTICE; EXERCISE; HUMAN; HYPNOSIS; INTEGRATIVE MEDICINE; LUNG CANCER; MASSAGE; META ANALYSIS (TOPIC); MOOD DISORDER; MUSIC THERAPY; NAUSEA; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; SLEEP DISORDER; SOCIAL SUPPORT; SYSTEMATIC REVIEW; YOGA;

EID: 84877655371     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2364     Document Type: Article

References (159)

1. Lewis SZ, Diekemper R, Addrizzo-Harris DJ. Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): 41S-50S.
2. Schmidt K. CAM and the desperate call for cancer cures and alleviation what can websites offer cancer patients? Complement Ther Med. 2002; 10 (3): 179-180.
3. Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol. 2004; 15 (5): 733-742.
4. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004; 9 (1): 80-89.
5. Remen RN. Practicing a medicine of the whole person: an opportunity for healing. Hematol Oncol Clin North Am. 2008; 22 (4): 767-773.
6. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States. Natl Health Stat Report. 2008; 10 (12): 1-23.
7. Wells M, Sarna L, Cooley ME, et al. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs. 2007; 30(1): 45-55.
8. Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med. 2002; 136 (5): 374-383.
9. Martin GP, Waite PM. The efficacy of acupuncture as an aid to stopping smoking. N Z Med J. 1981; 93 (686): 421-423.
10. Baldwin C, Spiro A, McGough C, et al. Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr Diet. 2011; 24 (5): 431-440.
11. Kumar NB, Kazi A, Smith T, et al. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol. 2010; 11 (3-4): 107-117.
12. Murphy RA, Mourtzakis M, Chu QS, Reiman T, Mazurak VC. Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J Nutr. 2010; 140 (9): 1602-1606.
13. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ. 1997; 315 (7117): 1219-1222.
14. Rivadeneira DE, Evoy D, Fahey TJ III, Lieberman MD, Daly JM. Nutritional support of the cancer patient. CA Cancer J Clin. 1998; 48 (2): 69-80.
15. Satia JA, Littman A, Slatore CG, Galanko JA, White E. Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev. 2009; 18 (5): 1419-1428.
16. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996; 88 (21): 1560-1570.
17. McCulloch M, See C, Shu XJ, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced nonsmall-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol. 2006; 24 (3): 419-430.
18. Szabo E, Mao JT, Lam S, Reid ME, Keith RL. Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): e40S-e60S.
19. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States. Natl Health Stat Report. 2009; (18): 1-14.
20. Adams J, Sibbritt DW, Easthope G, Young AF. The profile of women who consult alternative health practitioners in Australia. Med J Aust. 2003; 179 (6): 297-300.
21. Chrystal K, Allan S, Forgeson G, Isaacs R. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J. 2003; 116 (1168): U296.
22. Amin M, Glynn F, Rowley S, et al. Complementary medicine use in patients with head and neck cancer in Ireland. Eur Arch Otorhinolaryngol. 2010; 267 (8): 1291-1297.
23. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004; 22 (4): 671-677.
24. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002; 137 (11): 889-903.
25. Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006; 12 (6): 467-474.
26. Hyodo I, Amano N, Eguchi K, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005; 23 (12): 2645-2654.
27. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005; 16 (4): 655-663.
28. Gansler T, Kaw C, Crammer C, Smith T. A populationbased study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2008; 113 (5): 1048-1057.
29. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005; 4 (4): 274-286.
30. White MA, Verhoef MJ. Decision-making control: why men decline treatment for prostate cancer. Integr Cancer Ther. 2003; 2 (3): 217-224.
31. Shumay DM, Maskarinec G, Kakai H, Gotay CC; Cancer Research Center of Hawaii. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract. 2001; 50 (12): 1067.
32. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA. 1999; 282 (7): 651-656.
33. Montbriand MJ. Abandoning biomedicine for alternate therapies: oncology patients' stories. Cancer Nurs. 1998; 21 (1): 36-45.
34. Fjorback LO, Arendt M, Ornbøl E, Fink P, Walach H. Mindfulness-based stress reduction and mindfulness-based cognitive therapy: a systematic review of randomized controlled trials. Acta Psychiatr Scand. 2011; 124 (2): 102-119.
35. Shennan C, Payne S, Fenlon D. What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psychooncology. 2011; 20 (7): 681-697.
36. Ledesma D, Kumano H. Mindfulness-based stress reduction and cancer: a meta-analysis. Psychooncology. 2009; 18(6): 571-579.
37. Matchim Y, Armer JM. Measuring the psychological impact of mindfulness meditation on health among patients with cancer: a literature review. Oncol Nurs Forum. 2007; 34 (5): 1059-1066.
38. Smith JE, Richardson J, Hoffman C, Pilkington K. Mindfulnessbased stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs. 2005; 52 (3): 315-327.
39. Astin JA. Mind-body therapies for the management of pain. Clin J Pain. 2004; 20 (1): 27-32.
40. Bonadonna R. Meditation's impact on chronic illness. Holist Nurs Pract. 2003; 17 (6): 309-319.
41. Banasik J, Williams H, Haberman M, Blank SE, Bendel R. Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors. J Am Acad Nurse Pract. 2011; 23 (3): 135-142.
42. Eppley KR, Abrams AI, Shear J. Differential effects of relaxation techniques on trait anxiety: a meta-analysis. J Clin Psychol. 1989; 45 (6): 957-974.
43. Littman AJ, Bertram LC, Ceballos R, et al. Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer. 2012; 20(2): 267-277.
44. Chandwani KD, Thornton B, Perkins GH, et al. Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancer. J Soc Integr Oncol. 2010; 8 (2): 43-55.
45. Lin KY, Hu YT, Chang KJ, Lin HF, Tsauo JY. Effects of yoga on psychological health, quality of life, and physical health of patients with cancer: a meta-analysis. Evid Based Complement Alternat Med. 2011 :659876.
46. Vadiraja HS, Rao MR, Nagarathna R, et al. Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Complement Ther Med. 2009; 17 (5-6): 274-280.
47. Rao RM, Nagendra HR, Raghuram N, et al. Influence of yoga on mood states, distress, quality of life and immune outcomes in early stage breast cancer patients undergoing surgery. Int J Yoga. 2008; 1 (1): 11-20.
48. Smith KB, Pukall CF. An evidence-based review of yoga as a complementary intervention for patients with cancer. Psychooncology. 2009; 18 (5): 465-475.
49. Raghavendra RM, Nagarathna R, Nagendra HR, et al. Effects of an integrated yoga programme on chemotherapyinduced nausea and emesis in breast cancer patients. Eur J Cancer Care (Engl). 2007; 16 (6): 462-474.
50. Speed-Andrews AE, Stevinson C, Belanger LJ, Mirus JJ, Courneya KS. Pilot evaluation of an Iyengar yoga program for breast cancer survivors. Cancer Nurs. 2010; 33 (5): 369-381.
51. Carson JW, Carson KM, Porter LS, Keefe FJ, Shaw H, Miller JM. Yoga for women with metastatic breast cancer: results from a pilot study. J Pain Symptom Manage. 2007; 33 (3): 331-341.
52. Mansky P, Sannes T, Wallerstedt D, et al. Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivors. Integr Cancer Ther. 2006; 5 (3): 192-201.
53. Chan CL, Wang CW, Ho RT, et al. A systematic review of the effectiveness of qigong exercise in supportive cancer care. Support Care Cancer. 2012; 20 (6): 1121-1133.
54. Mustian KM, Katula JA, Zhao H. A pilot study to assess the influence of tai chi chuan on functional capacity among breast cancer survivors. J Support Oncol. 2006; 4 (3): 139-145.
55. Mustian KM, Katula JA, Gill DL, Roscoe JA, Lang D, Murphy K. Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer. 2004; 12 (12): 871-876.
56. Montgomery GH, Hallquist MN, Schnur JB, David D, Silverstein JH, Bovbjerg DH. Mediators of a brief hypnosis intervention to control side effects in breast surgery patients: response expectancies and emotional distress. J Consult Clin Psychol. 2010; 78 (1): 80-88.
57. Lang EV, Berbaum KS, Pauker SG, et al. Beneficial effects of hypnosis and adverse effects of empathic attention during percutaneous tumor treatment: when being nice does not suffice. J Vasc Interv Radiol. 2008; 19 (6): 897-905.
58. Montgomery GH, Bovbjerg DH, Schnur JB, et al. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst. 2007; 99 (17): 1304-1312.
59. Montgomery GH, David D, Winkel G, Silverstein JH, Bovbjerg DH. The effectiveness of adjunctive hypnosis with surgical patients: a meta-analysis. Anesth Analg. 2002; 94 (6): 1639-1645.
60. Montgomery GH, Kangas M, David D, et al. Fatigue during breast cancer radiotherapy: an initial randomized study of cognitive-behavioral therapy plus hypnosis. Health Psychol. 2009; 28 (3): 317-322.
61. Richardson J, Smith JE, McCall G, Richardson A, Pilkington K, Kirsch I. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care (Engl). 2007; 16 (5): 402-412.
62. Schnur JB, Bovbjerg DH, David D, et al. Hypnosis decreases presurgical distress in excisional breast biopsy patients. Anesth Analg. 2008; 106 (2): 440-444.
63. Stalpers LJ, da Costa HC, Merbis MA, Fortuin AA, Muller MJ, van Dam FS. Hypnotherapy in radiotherapy patients: a randomized trial. Int J Radiat Oncol Biol Phys. 2005; 61 (2): 499-506.
64. Rajasekaran M, Edmonds PM, Higginson IL. Systematic review of hypnotherapy for treating symptoms in terminally ill adult cancer patients. Palliat Med. 2005; 19 (5): 418-426.
65. Cassileth BR, Deng GE, Gomez JE, et al. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3):340S-354S.
66. Hilliard RE. Music therapy in hospice and palliative care: a review of the empirical data. Evid Based Complement Alternat Med. 2005; 2 (2): 173-178.
67. Nilsson U, Rawal N, Unosson M. A comparison of intraoperative or postoperative exposure to music-a controlled trial of the effects on postoperative pain. Anaesthesia. 2003; 58 (7): 699-703.
68. Dale HL, Adair PM, Humphris GM. Systematic review of posttreatment psychosocial and behaviour change interventions for men with cancer. Psychooncology. 2010; 19 (3): 227-237.
69. Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006; 36 (1): 13-34.
70. Kwekkeboom KL, Cherwin CH, Lee JW, Wanta B. Mindbody treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage. 2010; 39 (1): 126-138.
71. Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support Care Cancer. 2009; 17 (4): 333-337.
72. Wilkinson S, Barnes K, Storey L. Massage for symptom relief in patients with cancer: systematic review. J Adv Nurs. 2008; 63 (5): 430-439.
73. Cherkin DC, Sherman KJ, Deyo RA, Shekelle PG. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med. 2003; 138 (11): 898-906.
74. Corbin L. Safety and efficacy of massage therapy for patients with cancer. Cancer Contr. 2005; 12 (3): 158-164.
75. Ernst E. The safety of massage therapy. Rheumatology (Oxford). 2003; 42 (9): 1101-1106.
76. Arbane G, Tropman D, Jackson D, Garrod R. Evaluation of an early exercise intervention after thoracotomy for nonsmall cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised controlled trial. Lung Cancer. 2011; 71 (2): 229-234.
77. Jones LW, Eves ND, Peterson BL, et al. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer. 2008; 113 (12): 3430-3439.
78. Bobbio A, Chetta A, Ampollini L, et al. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008; 33 (1): 95-98.
79. Jones LW, Peddle CJ, Eves ND, et al. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer. 2007; 110 (3): 590-598.
80. Cesario A, Ferri L, Galetta D, et al. Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer. 2007; 57 (1): 118-119.
81. Cesario A, Ferri L, Galetta D, et al. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer. 2007; 57 (2): 175-180.
82. Riesenberg H, Lübbe AS. In-patient rehabilitation of lung cancer patients-a prospective study. Support Care Cancer. 2010; 18 (7): 877-882.
83. Spruit MA, Janssen PP, Willemsen SC, Hochstenbag MM, Wouters EF. Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer. 2006; 52 (2): 257-260.
84. Granger CL, McDonald CF, Berney S, Chao C, Denehy L. Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer. 2011; 72 (2): 139-153.
85. Arthur HM, Daniels C, McKelvie R, Hirsh J, Rush B. Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial. Ann Intern Med. 2000; 133 (4): 253-262.
86. Quist M, Rørth M, Langer S, et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer. 2012; 75 (2): 203-208.
87. Temel JS, Greer JA, Goldberg S, et al. A structured exercise program for patients with advanced non-small cell lung cancer. J Thorac Oncol. 2009; 4 (5): 595-601.
88. Ezzo JM, Richardson MA, Vickers A, et al. Acupuncturepoint stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006; (2): CD002285.
89. Streitberger K, Ezzo J, Schneider A. Acupuncture for nausea and vomiting: an update of clinical and experimental studies. Auton Neurosci. 2006; 129 (1-2): 107-117.
90. Enblom A, Johnsson A, Hammar M, Onelöv E, Steineck G, Börjeson S. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study. Ann Oncol. 2012; 23 (5): 1353-1361.
91. Sima L, Wang X. Therapeutic effect of acupuncture on cisplatin-induced nausea and vomiting [in Chinese]. Zhongguo Zhen Jiu. 2009; 29 (1): 3-6.
92. Nystrom E, Ridderstrom G, Leffler AS. Manual acupuncture as an adjunctive treatment of nausea in patients with cancer in palliative care-a prospective, observational pilot study. Acupunct Med. 2008; 26 (1): 27-32.
93. Yang Y, Zhang Y, Jing NC, et al. Electroacupuncture at Zusanli (ST 36) for treatment of nausea and vomiting caused by the chemotherapy of the malignant tumor: a multicentral randomized controlled trial [in Chinese]. Zhongguo Zhen Jiu. 2009; 29 (12): 955-958.
94. Taspinar A, Sirin A. Effect of acupressure on chemotherapyinduced nausea and vomiting in gynecologic cancer patients in Turkey. Eur J Oncol Nurs. 2010; 14 (1): 49-54.
95. Gottschling S, Reindl TK, Meyer S, et al. Acupuncture to alleviate chemotherapy-induced nausea and vomiting in pediatric oncology-a randomized multicenter crossover pilot trial. Klin Padiatr. 2008; 220 (6): 365-370.
96. You Q, Yu H, Wu D, Zhang Y, Zheng J, Peng C. Vitamin B6 points PC6 injection during acupuncture can relieve nausea and vomiting in patients with ovarian cancer. Int J Gynecol Cancer. 2009; 19 (4): 567-571.
97. Perkins P, Vowler SL. Does acupressure help reduce nausea and vomiting in palliative care patients? Pilot study. Palliat Med. 2008; 22 (2): 193-194.
98. Gardani G, Cerrone R, Biella C, et al. A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach. Minerva Med. 2007; 98 (6): 665-668.
99. Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain Res Treat. 2011; 920807.
100. Donald GK, Tobin I, Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med. 2011; 29 (3): 230-233.
101. Xu WR, Hua BJ, Hou W, Bao YJ. Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs [in Chinese]. Zhongguo Zhen Jiu. 2010; 30 (6): 457-460.
102. Schroeder S, Meyer-Hamme G, Epplée S. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupunct Med. 2012; 30 (1): 4-7.
103. Wong R, Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy-a case series. Acupunct Med. 2006; 24 (2): 87-91.
104. Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010; 28 (15): 2565-2570.
105. Crew KD, Capodice JL, Greenlee H, et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol. 2010; 28 (7): 1154-1160.
106. Crew KD, Capodice JL, Greenlee H, et al. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients. J Cancer Surviv. 2007; 1 (4): 283-291.
107. He JP, F riedrich M, Ertan AK, Müller K, Schmidt W. Painrelief and movement improvement by acupuncture after ablation and axillary lymphadenectomy in patients with mammary cancer. Clin Exp Obstet Gynecol. 1999; 26 (2): 81-84.
108. Deng G, Rusch V, Vickers A, et al. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. J Thorac Cardiovasc Surg. 2008; 136 (6): 1464-1469.
109. Wong RH, Lee TW, Sihoe AD, et al. Analgesic effect of electroacupuncture in postthoracotomy pain: a prospective randomized trial. Ann Thorac Surg. 2006; 81 (6): 2031-2036.
110. Vickers AJ, Rusch VW, Malhotra VT, Downey RJ, Cassileth BR. Acupuncture is a feasible treatment for post-thoracotomy pain: results of a prospective pilot trial. BMC Anesthesiol. 2006; 6 : 5.
111. Paley CA, Johnson MI. Acupuncture for cancer-induced bone pain: a pilot study. Acupunct Med. 2011; 29 (1): 71-73.
112. Lu W, Posner MR, Wayne P, Rosenthal DS, Haddad RI. Acupuncture for dysphagia after chemoradiation therapy in head and neck cancer: a case series report. Integr Cancer Ther. 2010; 9 (3): 284-290.
113. Dean-Clower E, Doherty-Gilman AM, Keshaviah A, et al. Acupuncture as palliative therapy for physical symptoms and quality of life for advanced cancer patients. Integr Cancer Ther. 2010; 9 (2): 158-167.
114. Guo R, Zhang L, Gong Y, Zhang B. The treatment of pain in bone metastasis of cancer with the analgesic decoction of cancer and the acupoint therapeutic apparatus. J Tradit Chin Med. 1995; 15 (4): 262-264.
115. Xu S, L iu Z, Xu M. Treatment of cancerous abdominal pain by acupuncture on zusanli (ST 36)-a report of 92 cases. J Tradit Chin Med. 1995; 15 (3): 189-191.
116. Chen ZJ, Guo YP, Wu ZC. Observation on the therapeutic effect of acupuncture at pain points on cancer pain [in Chinese]. Zhongguo Zhen Jiu. 2008; 28 (4): 251-253.
117. Li QS, Cao SH, Xie GM, et al. Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer. Chin Med J (Engl). 1994; 107 (4): 289-294.
118. Adams D, Cheng F, Jou H, Aung S, Yasui Y, Vohra S. The safety of pediatric acupuncture: a systematic review. Pediatrics. 2011; 128(6):e1575-1587.
119. Jindal V, Ge A, Mansky PJ. Safety and efficacy of acupuncture in children: a review of the evidence. J Pediatr Hematol Oncol. 2008; 30 (6): 431-442.
120. Ernst E, Lee MS, Choi TY. Acupuncture: does it alleviate pain and are there serious risks? A review of reviews. Pain. 2011; 152 (4): 755-764.
121. White A. A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med. 2004; 22 (3): 122-133.
122. Lao L, Hamilton GR, Fu J, Berman BM. Is acupuncture safe? A systematic review of case reports. Altern Ther Health Med. 2003; 9 (1): 72-83.
123. Ernst E, White AR. Prospective studies of the safety of acupuncture: a systematic review. Am J Med. 2001; 110 (6): 481-485.
124. MacPherson H, Thomas K, Walters S, Fitter M. A prospective survey of adverse events and treatment reactions following 34,000 consultations with professional acupuncturists. Acupunct Med. 2001; 19 (2): 93-102.
125. Yamashita H, Tsukayama H, White AR, Tanno Y, Sugishita C, Ernst E. Systematic review of adverse events following acupuncture: the Japanese literature. Complement Ther Med. 2001; 9 (2): 98-104.
126. Yamashita H, Tsukayama H, Tanno Y, Nishijo K. Adverse events in acupuncture and moxibustion treatment: a six-year survey at a national clinic in Japan. J Altern Complement Med. 1999; 5 (3): 229-236.
127. Boffetta P, Couto E, Wichmann J, et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2010; 102 (8): 529-537.
128. Vojacek J, Bis J, Dominik J, et al. Left coronary artery compression caused by a false aneurysm expansion after perforation of type A aortic dissection. J Card Surg. 2010; 25 (1): 72-73.
129. Carpenter CL, Yu MC, London SJ. Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California. Nutr Cancer. 2009; 61 (4): 492-499.
130. Büchner FL, Bueno-de-Mesquita HB, Ros MM, et al. Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2010; 19 (9): 2278-2286.
131. Kaufer D, Gandy S. APOE epsilon4 and bapineuzumab: infusing pharmacogenomics into Alzheimer disease therapeutics. Neurology. 2009; 73 (24): 2052-2053.
132. Dosil-Díaz O, Ruano-Ravina A, Gestal-Otero JJ, Barros-Dios JM. Consumption of fruit and vegetables and risk of lung cancer: a case-control study in Galicia, Spain. Nutrition. 2008; 24 (5): 407-413.
133. Struijker-Boudier HA. Retinal microcirculation and early mechanisms of hypertension. Hypertension. 2008; 51 (4): 821-822.
134. Linseisen J, Rohrmann S, Miller AB, et al. Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2007; 121(5): 1103-1114.
135. Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006; 9 (1A): 124-126.
136. Lam TK, Ruczinski I, Helzlsouer KJ, Shugart YY, Caulfield LE, Alberg AJ. Cruciferous vegetable intake and lung cancer risk: a nested case-control study matched on cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2010; 19 (10): 2534-2540.
137. Ito Y, Wakai K, Suzuki K, et al; JACC Study Group. Lung cancer mortality and serum levels of carotenoids, retinol, tocopherols, and folic acid in men and women: a casecontrol study nested in the JACC Study. J Epidemiol. 2005; 15 (suppl 2): S140-S149.
138. Neuhouser ML, Patterson RE, Thornquist MD, Omenn GS, King IB, Goodman GE. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev. 2003; 12 (4): 350-358.
139. Wu X, Zhu Y, Yan H, et al. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human nonsmall cell lung cancer cells. BMC Cancer. 2010; 10 : 269.
140. Tang L, Zirpoli GR, Jayaprakash V, et al. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. BMC Cancer. 2010; 10 : 162.
141. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res. 2007; 55 (3): 224-236.
142. Bor MV, von Castel-Roberts KM, Kauwell GP, et al. Daily intake of 4 to 7 microg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12-related biomarkers in a healthy young population. Am J Clin Nutr. 2010; 91 (3): 571-577.
143. Tang NP, Zhou B, Wang B, Yu RB, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol. 2009; 39 (6): 352-359.
144. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996; 88 (21): 1550-1559.
145. Yang WS, Va P, Wong MY, Zhang HL, Xiang YB. Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. Am J Clin Nutr. 2011; 94 (6): 1575-1583.
146. Aune D, De Stefani E, Ronco A, et al. Meat consumption and cancer risk: a case-control study in Uruguay. Asian Pac J Cancer Prev. 2009; 10 (3): 429-436.
147. Tasevska N, Sinha R, Kipnis V, et al. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr. 2009; 89 (6): 1884-1894.
148. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med. 2007; 4(12): e325.
149. Lim WY, Chuah KL, Eng P, et al. Meat consumption and risk of lung cancer among never-smoking women. Nutr Cancer. 2011; 63 (6): 850-859.
150. Tasevska N, Cross AJ, Dodd KW, Ziegler RG, Caporaso NE, Sinha R. No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial. Int J Cancer. 2011; 128 (2): 402-411.
151. Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer. 2008; 16 (5): 447-451.
152. Couch M, Lai V, Cannon T, et al. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck. 2007; 29 (4): 401-411.
153. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003; 52(10): 1479-1486.
154. Yin S, Hu SL, S hen G, et al. The effect of amino acid nutritional support on serum tryptophan and melatonin in lung cancer patients receiving chemotherapy [in Chinese]. Zhonghua Zhong Liu Za Zhi. 2006; 28 (11): 840-843.
155. Hamerman D. Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia. J Gerontol A Biol Sci Med Sci. 2002; 57 (8): M511-M518.
156. Maciver I, Hansen EJ. Lack of expression of the global regulator OxyR in Haemophilus influenzae has a profound effect on growth phenotype. Infect Immun. 1996; 64 (11): 4618-4629.
157. Fearon KC, Barber MD, Moses AG, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006; 24 (21): 3401-3407.
158. van der Meij BS, Langius JA, Smit EF, et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III nonsmall cell lung cancer during multimodality treatment. J Nutr. 2010; 140 (10): 1774-1780.
159. National Institutes of Health/National Center for Complementary and Alternative Medicine. What is complementary and alternative medicine? National Center for Complementary and Alternative Medicine website. http://nccam.nih. gov/health/whatiscam. Accessed January 6, 2013.